Skip to main content
. 2016 Apr 12;11(4):e0153533. doi: 10.1371/journal.pone.0153533

Fig 2. Recurrence-free and overall survival according to EGFR and HER3 expression in PB-type adenocarcinoma.

Fig 2

Kaplan Meier analysis of five-year recurrence-free survival in strata according to high and low expression of (A) EGFR and (C) HER3 and overall survival according to high and low expression of (B) EGFR and (D) HER3.